These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Antiretroviral therapy in patients infected with HIV-1]. Corti ME Medicina (B Aires); 1998; 58 Suppl 1():49-56. PubMed ID: 9674248 [No Abstract] [Full Text] [Related]
3. Another take on when to start and how to succeed. Friedland GH AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600 [No Abstract] [Full Text] [Related]
4. When to start therapy--and what to start with. Gallant JE Posit Aware; 1997; 8(1):22-3. PubMed ID: 11364093 [TBL] [Abstract][Full Text] [Related]
5. HIV: it's beginning to look like a chronic disease. del Rio C AIDS Clin Care; 2001 Sep; 13(9):82-3. PubMed ID: 11547601 [No Abstract] [Full Text] [Related]
7. Standard treatments for HIV, Spring 1997. Smith D AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255 [TBL] [Abstract][Full Text] [Related]
8. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression. Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396 [TBL] [Abstract][Full Text] [Related]
9. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients. Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023 [TBL] [Abstract][Full Text] [Related]
13. Anti-HIV agents. Atazanavir as a booster for protease inhibitors. TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850 [No Abstract] [Full Text] [Related]
14. Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients? Knobel H Clin Infect Dis; 2005 Jan; 40(1):164-6. PubMed ID: 15614707 [No Abstract] [Full Text] [Related]
15. Protease inhibitors: opium of the masses? Martinez LJ Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167 [No Abstract] [Full Text] [Related]
16. The pipeline: three to watch. Hawes J BETA; 2004; 16(4):13-5. PubMed ID: 15386838 [TBL] [Abstract][Full Text] [Related]
17. [HIV-infection: modern antiretroviral therapy]. Rockstroh JK; Spengler U Dtsch Med Wochenschr; 2004 Sep; 129(37):1921-4. PubMed ID: 15372371 [No Abstract] [Full Text] [Related]
18. Combination treatment -- study results. Treat Rev; 1996 Dec; (No 23):4-11. PubMed ID: 11364282 [TBL] [Abstract][Full Text] [Related]
19. The initial patient visit: choosing an optimal antiretroviral strategy. Laurence J AIDS Read; 2000 Dec; 10(12):686-7. PubMed ID: 11189732 [No Abstract] [Full Text] [Related]
20. Patient adherence, not viral load now most important in HIV therapy. Rep Med Guidel Outcomes Res; 2000 Feb; 11(3):6-7. PubMed ID: 11768406 [No Abstract] [Full Text] [Related] [Next] [New Search]